Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0906-2025Class II

BD Pyxis MedStation ES (Med ES Main), REF: 323; and BD Pyxis MedStation ES (Med ES Main Tower), REF: 352

CareFusion 303, Inc / initiated 2023-04-05 / Open, Classified / root cause: software

CareFusion 303, Inc. began a recall of BD Pyxis MedStation ES (Med ES Main), REF: 323; and BD Pyxis MedStation ES (Med ES Main Tower), REF: 352 on . FDA classified it as Class II and gives the reason as "Due to an automated dispensing cabinet software issue, when a medication single order contains more than one component and at least one is unavailable for a multi-item or combination order, the order may display as...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-0906-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
CareFusion 303, Inc
Product
BD Pyxis MedStation ES (Med ES Main), REF: 323; and BD Pyxis MedStation ES (Med ES Main Tower), REF: 352
Product code
BRY Cabinet, Table And Tray, Anesthesia
Reason for recall
Due to an automated dispensing cabinet software issue, when a medication single order contains more than one component and at least one is unavailable for a multi-item or combination order, the order may display as grayed out; alternate location tooltip will display "Server connection failed," not listing other area devices where unavailable item(s) may be found, which may lead to delayed therapy.
Root cause tag
software
FDA root cause
Software design
Action
On 4/5/2023, correction notices were sent to customers who were asked to do the following: A permission-based feature called "Global Find" can be used to obtain alternate storage locations of medication(s) not loaded (by pharmacy) or depleted at that device and is not impacted by this issue. 1) Review and confirm that backup procedures (which may include but may not necessarily be limited to keys, emergency medication supplies, alternate devices in proximity, etc.) are in place and staff have all been properly trained on them to avoid delays in access to medications. 2) Ensure this letter is forwarded to applicable facilities if devices have been transferred and that all appropriate personnel have been made aware of this issue. 3) Complete and return the enclosed Customer Response Form via email to [email protected] 4) Adverse health consequences experienced with the use of this product should be reported to BD at 1-800-727-6102 or via bd.com/self-service. Recall/Letter Questions: BD Customer Support, Phone: 1-866-583-8783, Phone Hours: 5:00am PST to 4:00pm PST (8:00am ET to 7:00pm ET), Monday - Friday A software update is available. BD will contact you to schedule a time to install the software update.
Quantity in commerce
622
Distribution
US Nationwide distribution in the states of NY, NC, LA.
Product codes and lots
Software v1.7.3. REF/UDI-DI: 323/10885403512667, 352/10885403512674

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0906-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0906-2025Class IIOngoingVoluntary: Firm initiated